Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM). Background: Bevacizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback